Arbutus Biopharma Corp (ABUS) — Financial Flexibility Index
Arbutus Biopharma Corp (ABUS) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $0.00 (operating CF $-8.11 Million minus capex $8.11 Million) represents 0% of total liabilities ($16.99 Million). Check ABUS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arbutus Biopharma Corp Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Arbutus Biopharma Corp across 28 annual periods. For the full cash flow conversion analysis, see Arbutus Biopharma Corp cash conversion from operations.
Annual Financial Flexibility Index for Arbutus Biopharma Corp (1998–2025)
Year-by-year free cash flow to debt coverage for Arbutus Biopharma Corp. Explore ABUS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-39.64 Million | $-39.64 Million | $18.04 Million | ▼ -16.7% |
| 2024 | -1.88x | $-64.67 Million | $-64.85 Million | $34.34 Million | ▲ +14.9% |
| 2023 | -2.21x | $-84.93 Million | $-85.94 Million | $38.38 Million | ▼ -271.9% |
| 2022 | -0.59x | $-34.84 Million | $-35.36 Million | $58.57 Million | ▲ +68.8% |
| 2021 | -1.90x | $-66.72 Million | $-67.53 Million | $35.05 Million | ▼ -30.5% |
| 2020 | -1.46x | $-51.21 Million | $-51.44 Million | $35.11 Million | ▲ +32.1% |
| 2019 | -2.15x | $-70.42 Million | $-71.01 Million | $32.79 Million | ▲ +11.0% |
| 2018 | -2.41x | $-66.76 Million | $-67.90 Million | $27.67 Million | ▼ -219.3% |
| 2017 | -0.76x | $-41.34 Million | $-48.60 Million | $54.70 Million | ▼ -2.2% |
| 2016 | -0.74x | $-53.89 Million | $-57.88 Million | $72.90 Million | ▼ -131.8% |
| 2015 | -0.32x | $-52.50 Million | $-54.78 Million | $164.61 Million | ▲ +15.3% |
| 2014 | -0.38x | $-11.37 Million | $-12.42 Million | $30.20 Million | ▲ +21.6% |
| 2013 | -0.48x | $-6.01 Million | $-6.74 Million | $12.52 Million | ▼ -116.8% |
| 2012 | 2.85x | $33.29 Million | $33.27 Million | $11.68 Million | ▲ +424.6% |
| 2011 | -0.88x | $-7.46 Million | $-7.52 Million | $8.50 Million | ▲ +13.3% |
| 2010 | -1.01x | $-10.42 Million | $-11.25 Million | $10.29 Million | ▼ -82.3% |
| 2009 | -0.56x | $-3.62 Million | $-5.24 Million | $6.51 Million | ▲ +70.1% |
| 2008 | -1.85x | $-7.52 Million | $-8.48 Million | $4.05 Million | ▼ -784.4% |
| 2007 | -0.21x | $-1.36 Million | $-2.72 Million | $6.46 Million | ▲ +51.2% |
| 2006 | -0.43x | $-2.53 Million | $-2.62 Million | $5.88 Million | ▼ -9.5% |
| 2005 | -0.39x | $-14.53 Million | $-14.57 Million | $36.99 Million | ▼ -615.2% |
| 2004 | -0.05x | $-2.83 Million | $-9.98 Million | $51.60 Million | ▲ +98.5% |
| 2003 | -3.56x | $-26.18 Million | $-26.96 Million | $7.35 Million | ▼ -73.0% |
| 2002 | -2.06x | $-16.21 Million | $-18.16 Million | $7.87 Million | ▼ -39.1% |
| 2001 | -1.48x | $-9.06 Million | $-10.00 Million | $6.12 Million | ▲ +54.7% |
| 2000 | -3.27x | $-8.15 Million | $-8.35 Million | $2.49 Million | ▲ +4.0% |
| 1999 | -3.40x | $-6.54 Million | $-6.84 Million | $1.92 Million | ▼ -6.6% |
| 1998 | -3.19x | $-4.49 Million | $-7.71 Million | $1.40 Million | — |